Carmel, Indiana, May 7, 2024 /PRNewswire/ — Syra Health Corp. (NASDAQ: SYRA) (“Syra Health” or the “Company”), A healthcare technology company with a mission to improve health care by providing innovative services and technology solutions today announced it has been awarded a contract to conduct a comprehensive needs assessment of residents living in the region. Middlesex County, New Jerseyand develop community health improvement plans to support those populations.
Syra Health conducts comprehensive needs assessments by collecting data from national, state, and local data sources, customer surveys, and external community focus groups. A comprehensive needs assessment helps counties determine spending for the health, behavioral health, and community service needs of all people. middlesex province residents. The Community Health Improvement Plan outlines priorities for improving health outcomes within the county and provides an approach to address public health concerns raised by the Community Health Assessment.
“We are honored to collaborate with a variety of local stakeholders and leverage our expertise in epidemiology and data analysis to support this community's health improvement journey,” said Dr. Srikanth DevarajVice President of Data Analytics and Leader of the Population Health Business Unit; Shira Health.
This project aligns with Syra Health's goal of providing innovative healthcare technology solutions and supporting community health improvement efforts.
“Community assessments are in high demand across local and state governments, and we expect similar projects to be repeated,” he said. deepika bhuparanchiCEO, Shira Health.
About Shira Health
Syra Health is a healthcare technology company that provides innovative services and technology solutions to address some of healthcare's most important challenges in areas such as behavioral and mental health, digital health, and population health. Syra Health's products and services are focused on prevention, improved access and affordable care. Syra Health provides its solutions to payers, healthcare providers, life sciences organizations, academic institutions, and governments. For more information, please visit www.syrahealth.com.
Forward-looking statements
Statements in this press release regarding future expectations, plans, forward-looking statements and other statements regarding matters that are not historical facts may constitute “forward-looking statements.” These statements include, but are not limited to, statements regarding the anticipated use of proceeds, the Company's operating and business strategies, and the Company's expected financial results. “anticipate”, “believe”, “continue”, “could”, “estimate”, “expect”, “intend”, “may”, “plan”, “could” Words such as “should,” “anticipate,” “plan,” “should,” “target,” “will,” “will” and similar expressions identify forward-looking statements. However, not all forward-looking statements contain these identifiable words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to significant risks, uncertainties and changes in circumstances. Investors should read the risk factors included in the Form 10-K for the ended year. December 31, 2023, and other periodic reports filed with the Securities and Exchange Commission. The forward-looking statements contained in this press release speak only as of the date of this press release and, except as required by federal securities laws, the Company does not intend to make any changes, whether as a result of new information or not. We specifically disclaim any obligation to update any forward-looking statements. future events, etc.
For more information, please contact us below.
Media inquiries:
Christine Drury
Communications and Marketing Director
Shira Health
463-345-5180
[email protected]
Investor inquiries:
Ben Shamsyan
vice president
Lytham Partners LLC
646-829-9701
[email protected]
Source: Shira Health
